Menopause and body composition: why the scale won't move even when you train?

Perimenopause is the transition before the final menstrual period, during which ovulation changes and hormone levels fluctuate. Age-related change continues during the same life stage. Together, these factors can affect fat quantity and distribution as well as muscle mass and strength, even when body weight looks similar.

According to the large US SWAN study (Study of Women's Health Across the Nation), published in JCI Insight, the rate of fat gain roughly doubles around the menopause transition, while lean, largely muscle mass declines. These changes aren't spread evenly across a woman's life – they accelerate specifically around the transition and, per the same study, settle again roughly two years after the final period.

That's exactly why the bathroom scale is a misleading indicator during this phase. Muscle loss and fat gain can partly cancel each other out on the scale – a kilogram of muscle lost and a kilogram of fat gained show up identically in the number, even though for your health and metabolism they represent opposite trends. The number stays put while the ratio of muscle, fat and water underneath keeps shifting.

Lower estradiol is one plausible contributor to a shift of fat toward the trunk and to the female pattern of muscle ageing. Observational studies and mechanistic reviews cannot cleanly separate the transition from age, activity, sleep and other influences.

A systematic review found lower muscle mass and strength after menopause than before it, while noting uncertainty around mechanisms and the causal role of estrogen. A fat-mass meta-analysis attributed most differences between pre- and postmenopausal groups to increasing age rather than an additional independent effect of menopausal status.

It's worth not treating these mechanisms as a fixed script that plays out identically for every woman. The speed and extent of the changes vary considerably between individuals – genetics, activity level, diet, sleep and overall health all play a role. What the research explains is why changes tend to happen faster and more often during this life stage, not exactly what will happen, or how strongly, in your specific case.

InBody 970/970S uses bioimpedance to estimate skeletal muscle mass, body fat, visceral fat and water compartments. It also calculates phase angle from resistance and reactance. These are not direct images of tissue or a test of “cellular health.”

The device does not measure estrogen or FSH, bone density or osteoporosis. In people aged 45 or older, menopause is usually identified clinically from symptoms and menstrual history; laboratory tests are reserved for selected situations. That assessment belongs to a healthcare professional.

This distinction is worth stating plainly, because it's easy to mistake body composition results for the full health picture. InBody gives you an objective, measurable view of muscle, fat and water in the body – an important piece of the puzzle, not the whole picture. For the broader health context, including hormones and bone, other tests and a specialist's assessment still belong in the mix.

A single InBody measurement is like a photo – it captures where things stand right now but says nothing about the direction your body is heading. A series of measurements over time is more like a film: it shows the trend. In perimenopause, where changes happen gradually and often without noticeable day-to-day differences, the trend matters far more than any one number.

A trend can reveal a repeated direction that the scale misses. If estimated muscle is stable and the fat trend falls under comparable conditions, that is more informative than weight alone. These remain BIA estimates and should be read with strength and function.

To keep the trend readable and not distorted by short-term noise, it helps to compare measurements taken under similar conditions – roughly the same time of day, similar hydration, not right after an intense workout – and at a similar interval between sessions. Short-term swings, for example around the menstrual cycle, can temporarily shift a result without reflecting any real change in body composition.

Strength training – resistance exercise with weights, bands or bodyweight – is, according to systematic reviews and meta-analyses of randomized trials published in journals such as BMC Women's Health, among the best-supported and safest interventions against the loss of strength and muscle mass associated with menopause. Women who train regularly typically show preserved or slightly increased muscle mass across these studies; the effect on fat mass itself is more variable in the research and often shows up more clearly when strength training is combined with added aerobic activity and dietary changes.

Without treating this as a medical prescription, the research generally points to consistency and gradual progression of load as the factors that matter most – the body adapting over time to slowly increasing demands, rather than any single 'magic' type of exercise. Combining strength training with adequate protein intake shows up repeatedly in the research as a sound foundation to build on.

Strength training at this life stage is not just about appearance. Strength and muscle mass relate to later function. InBody can estimate a muscle-mass trend, but changes in strength need a functional test or performance measure, not bioimpedance.

Hormone replacement therapy (HRT) supplies the body with hormones it's missing, primarily estrogen, in medication form. Some cohort studies, such as the Swiss OsteoLaus study published in the Journal of Clinical Endocrinology and Metabolism, have observed lower total and visceral adiposity among women using HRT compared with those who don't. That's an observational finding from specific cohorts, though, not proof that HRT changes body composition the same way for every woman.

The decision to start hormone replacement therapy is always individual and medical – it weighs far more than body composition alone, including family history, other risk factors and personal priorities. That decision belongs exclusively to a gynecologist or endocrinologist; no InBody measurement, and no body composition tracking, can replace it.

What does make sense is treating the trend in muscle, fat and visceral fat as one piece of information to discuss with your doctor when weighing next steps – not as an argument for or against therapy on its own. In that sense, objective InBody data works as a complement to professional assessment, not a substitute for it.

When reading an InBody result during perimenopause and menopause, it's worth focusing mainly on two trends: how muscle mass is moving over time, and how visceral fat is moving over time. It's also worth adding context the number alone won't capture – waist circumference, energy levels through the day, sleep quality, and how your clothes fit.

It's worth paying closer attention and consulting a specialist if muscle mass drops quickly and unexpectedly, if visceral fat keeps climbing noticeably despite regular training and a reasonable diet, or if these changes come with other symptoms – significant fatigue, sleep disruption, or cycle irregularities. In those cases, the InBody trend is a good reason to start a conversation with your doctor, not a substitute for their evaluation.

The goal of tracking body composition at this stage of life isn't to reverse menopause – no device or training plan can do that. The goal is having an objective tool that shows your effort is working, even when the bathroom scale doesn't reflect it. For a lot of women, that's exactly why they keep measuring through the period when motivation might otherwise be easiest to lose.